Usefulness of routine conventional cytogenetic analysis in tissues submitted for “lymphoma work-up”

References

• Jaffe E, Harris N, Stein H, Vardiman J W. Tumours of Haematopoietic and Lymphoid Tissues. IARC Press, LyonFrance 2001, World Health Organization Classification of Tumours
   Google Scholar
• Cook J R, Shekter-Levin S, Swerdlow S H. Utility of routine classical cytogenetic studies in the evaluation of suspected lymphomas. Am J Clin Pathol 2004; 121: 826–835
   PubMed Web of Science ®Google Scholar
• ISCN (1995). An International System for Human Cytogenetic Nomenclature, F. Mitelman. S. Karger, Basel 1995
   Google Scholar
• Berend S A, Canun S, McCaskill C, Page S L, Shaffer L G. Molecular analysis of mosaicism for two different de novo acrocentric rearrangements demonstrates diversity in Robertsonian translocation formation. Am J Med Genetics 1998; 80: 252–259
   PubMed Web of Science ®Google Scholar
• Dohner H, Stilgenbauer S, Benner A, Leupolt E, Kröber A, Bullinger L, et al. Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med 2000; 343: 1910–1916
   PubMed Web of Science ®Google Scholar
• Ripolles L, Ortega M, Ortuno F, González A, Losada J, Ojanguren J, et al. Genetic abnormalities and clinical outcome in chronic lymphocytic leukemia. Cancer Genetics Cytogenetics 2006; 171: 57–64
   PubMed Web of Science ®Google Scholar
• Dewald G W, Brockman S R, Paternoster S F, Bone N D, O'Fallon J R, Allmer C, et al. Chromosome in situ hybridization: correlation with significant features of B-cell chronic lymphocytic leukaemia. Br J Haematol 2003; 121: 287–295
   PubMed Web of Science ®Google Scholar
• Kern W, Haferlach T, Schnittger S, Schoch C. Detection of t(14;18)(q32;q21) in B-cell chronic lymphocytic leukemia. Arch Path Lab Med 2005; 129: 410–411
   PubMed Web of Science ®Google Scholar
• Dyer M JS, Zani V J, Lu W Z, O'Byrne A, Mould S, Chapman R, et al. BCL2 translocations in leukemias of mature B cells. Blood 1994; 83: 3682–3688
   PubMed Web of Science ®Google Scholar
• Kojima K, Taniwaki M, Yoshino T, Katayama Y, Sunami K, Fukuda S, et al. Trisomy 12 and t(14;18) in B-cell chronic lymphocytic leukemia. Int J Hematol 1998; 67: 199–203
   PubMed Web of Science ®Google Scholar
• Nowakowski G S, Dewald G W, Hoyer J D, Paternoster S F, Stockero K J, Fink S R, et al. Interphase fluorescence in situ hybridization with an IGH probe is important in the evaluation of patients with a clinical diagnosis of chronic lymphocytic leukaemia. Br J Haematol 2005; 130: 36–42
   PubMed Web of Science ®Google Scholar
• Frater J L, Tsiftsakis E, His E, Pettay J, Tubbs R R. Use of novel t(11;14) and t(14;18) dual-fusion fluorescence in situ hybridization probes in the differential diagnosis of lymphomas of small lymphocytes. Diagn Molec Path 2001; 10: 214–222
   PubMed Web of Science ®Google Scholar
• Karnolsky I N. Cytogenetic abnormalities in chronic lymphocytic leukemia. Folia Med (Plovdiv) 2000; 42: 5–10
   PubMedGoogle Scholar
• Athanasiadou A, Stamatopoulos K, Tsompanakou A, Gaitatzi M, Kalogiannidis P, Anagnostopoulos A, et al. Clinical, immunophenotypic, and molecular profiling of trisomy 12 in chronic lymphocytic leukemia and comparison with other karyotypic subgroups defined by cytogenetic analysis. Cancer Genet Cytogenet 2006; 168: 109–119
   PubMed Web of Science ®Google Scholar
• Godon A, Moreau A, Talmant P, Baranger-Papot L, Geneviève F, Milpied N, et al. Is t(14;18)(q32;q21) a constant finding in follicular lymphoma? An interphase FISH study on 63 patients. Leukemia 2003; 17: 255–259
   PubMed Web of Science ®Google Scholar
• Horsman D E, Connors J M, Pantzar T, Gascoyne R D. Analysis of secondary chromosomal alterations in 165 cases of follicular lymphoma with t(14;18). Genes Chromosomes Cancer 2001; 30: 375–382
   PubMed Web of Science ®Google Scholar
• Hoglund M, Sehn L, Connors J M, Gascoyne R D, Siebert R, Säil T, et al. Identification of cytogenetic subgroups and karyotypic pathways of clonal evolution in follicular lymphomas. Genes Chromosomes Cancer 2004; 39: 195–204
   PubMed Web of Science ®Google Scholar
• Ott G, Katzenberger T, Lohrs, Kindelberger S, Rüdiger T, Wilhelm M, et al. Cytomorphologic, immunohistochemical, and cytogenetic profiles of follicular lymphoma: 2 types of follicular lymphoma grade 3. Blood 2002; 99: 3806–3812
   PubMed Web of Science ®Google Scholar
• Bosga-Bouwer A G, van Imhoff G W, Boonstra R, van der Veen A, Haralambieva E, van den Berg A, et al. Follicular lymphoma grade 3B includes 3 cytogenetically defined subgroups with primary t(14;18), 3q27, or other translocations: t(14;18) and 3q27 are mutually exclusive. Blood 2003; 101: 1149–1154
   PubMed Web of Science ®Google Scholar
• Hsi E D, Mirza I, Lozanski G, Pohlman B, Karafa M T, Coupland R, et al. A clinicopathologic evaluation of follicular lymphoma grade 3A versus grade 3B reveals no survival differences. Arch Path Lab Med 2004; 128: 863–868
   PubMed Web of Science ®Google Scholar
• de la Fouchardiere A, Gazzo S, Balme B, Chouvet B, Felman P, Coiffier B, et al. Cytogenetic and molecular analysis of 12 cases of primary cutaneous marginal zone lymphomas. Am J Dermatopath 2006; 28: 287–292
   PubMed Web of Science ®Google Scholar
• Voorhees P M, Carder K A, Smith S V, Ayscue L H, Rao K W, Dunphy C H, et al. Follicular lymphoma with a Burkitt translocation—predictor of an aggressive clinical course. Arch Path Lab Med 2004; 128: 210–213
   PubMed Web of Science ®Google Scholar
• Lepretre S, Buchonnet G, Stamatoullas A, Lenain P, Duval C, d'Anjou J, et al. Chromosome abnormalities in peripheral T-cell lymphoma. Cancer Genet Cytogenet 2000; 117: 71–79
   PubMed Web of Science ®Google Scholar
• McKhann C F. Primary malignancy in patients undergoing immunosuppression for renal transplantation. Transplantation 1969; 8: 209–212
   PubMed Web of Science ®Google Scholar
• Chadburn A, Chen J M, Hsu D T, Frizzera G, Cesarman E, Garrett T J, et al. The morphologic and molecular genetic categories of posttransplantation lymphoproliferative disorders are clinically relevant. Cancer 1998; 82: 1978–1987
   PubMed Web of Science ®Google Scholar
• Mourad W A, Tulabah A, Al Sayed A, et al. The impact of the World Health Organization classification and clonality assessment of post-transplant lymphoproliferative disorders on disease management. Arch Pathol Lab Med 2006; 130: 1649–1653
   PubMed Web of Science ®Google Scholar
• Liu L B, Liu L, Wang X B, et al. Cytobiological and clinicobiological features of AML with 11q23 chromosome abnormalities. Zhongguo Shi Yan Xue Za Zhi 2005; 13: 932–936
   PubMedGoogle Scholar